| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $1.48 (Beat by $0.14) |
| EPS GAAP Actual | $1.48 (Beat by $0.14) |
| Revenue Actual | $0.495292B |
| Revenue Surprise | Beat by $495.292M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.46455 |
| EPS GAAP Estimate | $2.46455 |
| Revenue Estimate | $0.4276177B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 8.28 | 6.79 | 7.98743 | 8.58541 | 0 |
| Dec 2025 | 6.76 | 8.32 | 6.76 | 6.76 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.5 | -0.0038199999999999 | 0.495292B | 29.14% | 132.02M |
| FQ2 2025 (Jun 2025) | 1.87 | 1.87 | 0.39382B | 19.75% | 393.82M |
| FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 0.344873B | 15.71% | 344.87M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.0887B | -726.05% | 88.7M |
| FQ3 2024 (Sep 2024) | 1.58 | 1.58 | 0.350954B | 15.97% | 350.95M |
| FQ2 2024 (Jun 2024) | 1.22 | 1.22 | 0.316023B | 7.97% | 316.02M |
| FQ1 2024 (Mar 2024) | 1.35 | 1.35 | 0.290706B | 78.45% | 290.71M |
| FQ4 2023 (Dec 2023) | -4.45 | -4.45 | 0.732709B | -4.95% | 732.71M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.46455
Consensus Revenue Estimates
0.4276177B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.62 | -- | 2.47733 | 2.72956 | 1 |
| FQ3 2027 (Sep 2027) | 2.41 | -- | 2.24839 | 2.62442 | 1 |
| FQ2 2027 (Jun 2027) | 2.03 | -- | 1.89387 | 2.21061 | 1 |
| FQ1 2027 (Mar 2027) | 4.47 | -- | 4.17024 | 4.86771 | 1 |
| FQ4 2026 (Oct 2026) | 2.25 | -- | 2.19128 | 2.33123 | 0 |
| FQ3 2026 (Jul 2026) | 2.07 | 27.54 | 2.01598 | 2.14473 | 0 |
| FQ2 2026 (Jun 2026) | 1.62185 | -15.3 | 1.56905 | 1.65566 | 0 |
| FQ1 2026 (Mar 2026) | 2.46455 | 24.94 | 2.38432 | 2.51593 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.58B | -- | 0.56B | 0.6B | 2 |
| FQ3 2027 (Sep 2027) | 0.6B | -- | 0.57B | 0.64B | 2 |
| FQ2 2027 (Jun 2027) | 0.55B | -- | 0.52B | 0.59B | 2 |
| FQ1 2027 (Mar 2027) | 0.53B | -- | 0.51B | 0.57B | 2 |
| FQ4 2026 (Oct 2026) | 0.48B | -- | 0.47B | 0.49B | 1 |
| FQ3 2026 (Jul 2026) | 0.45B | -8.99 | 0.45B | 0.47B | 1 |
| FQ2 2026 (Jun 2026) | 0.44B | 10.76 | 0.43B | 0.45B | 1 |
| FQ1 2026 (Mar 2026) | 0.43B | 19.35 | 0.42B | 0.43B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.50382 | 1.5 | -0.0038199999999999 | -0.25% |
| FQ2 2025 (Jun 2025) | 1.87 | 1.87 | 100% | |
| FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 1.58 | 1.58 | 100% | |
| FQ2 2024 (Jun 2024) | 1.22 | 1.22 | 100% | |
| FQ1 2024 (Mar 2024) | 1.35 | 1.35 | 100% | |
| FQ4 2023 (Dec 2023) | -4.45 | -4.45 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.36B | $0.5B | $132.02M | 26.65% |
| FQ2 2025 (Jun 2025) | $0B | $0.39B | $393.82M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.34B | $344.87M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.09B | $88.7M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.35B | $350.95M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.32B | $316.02M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.29B | $290.71M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.73B | $732.71M | 100% |